active Therapeutic neutralization of the Interleukin-17 pathway in ALS Understanding Microbial Contributions to ALS Inflammatory networks that mediate cognitive decline in Alzheimer’s Disease Development of probiotics to slow ALS Single cell approaches to identify contributions to neurodegenerative disease T cell determinants of inherited FTD/ALS past